Today on Outsourcing-Pharma.com   FDA mix-up caused failure to inspect Baxter's Chinese supplier European CRO joins first Chinese CRO alliance Cambrex cost cutting beginning to pay Preclinical services news in brief West Pharmaceutical and Nektar formerly sever Exubera ties

Related Industry News   Fentanyl patches recalled over leakage risk EU white paper urges competitive spirit in research FDA starts inspecting stalled Watson facility Pfizer expands in inhaled drugs as Nektar cuts back

Breaking News on Outsourcing Pharma
Daily  21-Feb-2008		Forward to a colleague

	Sponsored Link Contract Biotechnology And Sterile Pharmaceutical Manufacturing Services Catalent Pharma Solutions offers a full range of manufacturing services from clinical through commercial-scale manufacturing and packaging. Multiple sites, capacity duplication and experience with almost every sterile dose form, make us the best choice for pharmaceutical... Click Here Access Full Stories FDA mix-up caused failure to inspect Baxter's Chinese supplier More details have emerged over the US Food and Drug Administration's (FDA's) failure to vet the Chinese manufacturing plant implicated in the Baxter heparin scare - the agency mistook it for an already-inspected... Read European CRO joins first Chinese CRO alliance Europe's Novasecta has formed an alliance with Chinese contract research organisations (CROs) Sundia Meditech and HD BioSciences to provide their R&D services to European mid-sized biopharma firms... Read Cambrex cost cutting beginning to pay Cambrex' cost cutting resolve is starting to pay off for the firm, who achieved an improved profitability in the fourth quarter of 2007, although sales are still stagnant... Read Preclinical services news in brief In this week's review of activity within the preclinical research services arena, news has emerged involving Genstruct, Morphosys, Xencor and GVK Biosciences... Read West Pharmaceutical and Nektar formerly sever Exubera ties West Pharmaceutical Services has formally announced the end of its Exubera relationship with the product's developers Nektar Therapeutics... Read
	All News Headlines for: February | January | December
	Product Brochure A revolution in Sales Lead Generation! - Free Download Promote your products and technology towards our readers, and we'll build a detailed profile of each person who reads your presentation document... Download our FREE Smart Lead Generation brochure now!... Click Here
	Related Industry News Fentanyl patches recalled over leakage risk Concerns have been building across North America about the safety of transdermal patches - both brandname and generic - for delivering the highly potent narcotic analgesic fentanyl... Read EU white paper urges competitive spirit in research The EMRC has called for increased funding within the European medical research community to maintain high standards and attract the brightest young researchers... Read FDA starts inspecting stalled Watson facility An end may be in sight to the long-running problems with the Florida manufacturing facility acquired by US brand and generic company Watson Pharmaceuticals with Andrx Corporation in November 2006... Read Pfizer expands in inhaled drugs as Nektar cuts back Pfizer's announcement of plans to create a new €130m inhaled medicines unit at its facility in Amboise, France suggests that the firm is still intent on investing in inhalation technology, despite its disappointment... Read Weekly comment Emerging markets 'hot' for VC, says KPMG Emerging markets, headed by China and India are tipped to remain hot destinations for venture capital (VC) investments this year, according to a recent survey by KPMG. Read Sponsored Link DPT - The Industry Source for Semi-solids and Liquids. DPT is a contract development and manufacturing organization (CDMO) specializing in semi-solid and liquid dosage forms providing solutions from concept to commercialization. Click here to learn more about our services... Click Here Previous Headlines Charles River accelerates China plans; reports profit jump Charles River Laboratories has reported another profit jump in its Q4 2007 financial results and has also stepped up its China plans as the demand for its preclinical services in the country are said to be "robust"... Read NPIL and Lilly form 'risk and reward' sharing alliance Nicholas Piramal (NPIL) has signed an innovative drug development deal with Eli Lilly - the second such agreement in a year... Read Pharmaceutical outsourcing: people on the move Shasun Chemicals, Patheon, Tepnel Research, ClinPhone and PharmEng have all had people on the move in the world of pharmaceutical outsourcing... Read Aceto makes determined pitch for Japanese intermediates Aceto, the US-based distributor and marketer of fine and industrial chemicals, is making a determined pitch for the pharmaceutical intermediates sector in Japan... Read Evotec scores $37m contract expansion Germany's Evotec has scored a three year contract extension with an existing US client worth up to $37m... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Product Information - brochures, Web centers Introducing Catalent Pharma Solutions - Company Profile Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com